NATURE PHARMA NORGE AS
Organization
- CEO
- DT
- Chairman of the board
- TA
- Years since formation
- 5 years
- since Nov 6, 2020
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 80,000
- 1 share class
- Total number of shareholders
- 3
- 2 companies, 1 person
Financials
- Total operating income 2024
- 45,881,556
- NOK
- Annual total result 2024
- 6,393,987
- NOK
- Total equity 2024
- 10,459,276
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
DT | Managing Director/CEO | - |
Board
Name | Role | Shares |
---|---|---|
TA | Chairman | 50 % indirectly |
Board Member | 50 % directly 25.5 % indirectly 24.5 % |
Others
Name | Role | Shares |
---|---|---|
Accountant | - | |
Auditor | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
TA | Chairman | 50 % indirectly |
Board Member | 50 % directly 25.5 % indirectly 24.5 % |
Last update: Aug 29, 2023
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 40,000 | 50 % | |
Ordinary shares | 20,400 | 25.5 % | |
Ordinary shares | 19,600 | 24.5 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 45,881,556 | 28,066,598 | 8,852,524 | 2,391,953 |
Annual Total Result | 6,393,987 | 3,499,739 | 460,470 | 44,793 |
Total assets | 16,659,164 | 7,254,255 | 2,596,771 | 1,200,919 |
Total liabilities | 6,199,888 | 3,188,966 | 2,031,222 | 1,095,840 |
Total equity | 10,459,276 | 4,065,289 | 565,550 | 105,079 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 45,881,556 | 28,066,598 | 8,852,524 | 2,391,953 |
Total operating costs | 37,860,896 | 23,558,957 | 8,183,436 | 2,309,651 |
Operating result | 8,020,660 | 4,507,641 | 669,088 | 82,302 |
Financial income/costs | 185,321 | -125,073 | -2,401 | -383 |
Profit before tax | 8,205,981 | 4,382,567 | 666,687 | 81,918 |
Total tax & extraordinary income/cost | 1,811,994 | 882,828 | 206,217 | 37,125 |
Annual Total Result | 6,393,987 | 3,499,739 | 460,470 | 44,793 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 1,562,625 | 58,641 | 0 | 0 |
Total current assets | 15,096,539 | 7,195,614 | 2,596,771 | 1,200,919 |
Total assets | 16,659,164 | 7,254,255 | 2,596,771 | 1,200,919 |
Short term debt | 5,475,325 | 3,188,966 | 1,211,222 | 275,840 |
Long term debt | 724,563 | 0 | 820,000 | 820,000 |
Total liabilities | 6,199,888 | 3,188,966 | 2,031,222 | 1,095,840 |
Contributed capital | 80,000 | 80,000 | 74,430 | 74,430 |
Retained earnings | 10,379,276 | 3,985,289 | 491,120 | 30,649 |
Total equity | 10,459,276 | 4,065,289 | 565,550 | 105,079 |
Total equity and liabilities | 16,659,164 | 7,254,255 | 2,596,771 | 1,200,919 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises